• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯卡西姆地区肾细胞癌的流行病学及治疗结果:一项回顾性研究

Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study.

作者信息

Alharbi Badr, Alnosayan Hatim S, Al-Harbi Faisal Awadh, Alaidah Alwleed M, Almoshiqeh Albaraa Nasser, Alharbi Abdullah Mulfi, Alwashmi Emad, Altwairgi Adil Khalaf

机构信息

Surgery, College of Medicine, Qassim University, Buraydah, SAU.

Urology, Medical City, Qassim University, Buraydah, SAU.

出版信息

Cureus. 2024 Oct 31;16(10):e72748. doi: 10.7759/cureus.72748. eCollection 2024 Oct.

DOI:10.7759/cureus.72748
PMID:39618569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11607626/
Abstract

INTRODUCTION AND AIM

Renal cell carcinoma (RCC) is an aggressive malignant neoplasm that accounts for 90% of renal cancers with rising incidence worldwide. This study aimed to analyze the demographics and clinical profiles, histopathological presentations, and treatment outcomes of 73 RCC patients at a hospital in Qassim region, Saudi Arabia.

METHODOLOGY

This retrospective observational study was conducted at King Fahad Specialist Hospital, Buraidah, from October 2017 to July 2024. Census sampling included all patients diagnosed with RCC. Data on demographics, clinical, and histopathological characteristics were analyzed using SPSS version 26 (Armonk, NY: IBM Corp.).

RESULTS

RCC was found to be more prevalent in males and older patients with common comorbidities such as diabetes and hypertension. Among the histopathological types of RCC, clear cell RCC (ccRCC) is most frequently reported in 60.3% of patients, followed by chromophobe RCC (chRCC) and papillary RCC (pRCC), in 16.4% and 11% of patients, respectively. Fuhrman grade 2 stage was seen in 65.8% of the tumors, indicating its moderately aggressive form. Incidental diagnoses accounted for 45.2% of patients, with 93.2% demonstrating no evidence of metastasis at diagnosis. The primary mode of treatment of RCC was the surgical procedure with laparoscopy, which was undergone in 52.1% of cases.

CONCLUSION

ccRCC exhibits the highest prevalence among the various forms of renal cancer, with the majority of cases being diagnosed incidentally. Despite the rising incidence, early diagnosis and improved screening strategies are yet to be elucidated to address the growing burden of RCC and its incidental finding rate in the Qassim region.

摘要

引言与目的

肾细胞癌(RCC)是一种侵袭性恶性肿瘤,占肾癌的90%,在全球范围内发病率呈上升趋势。本研究旨在分析沙特阿拉伯卡西姆地区一家医院73例肾细胞癌患者的人口统计学和临床特征、组织病理学表现及治疗结果。

方法

本回顾性观察研究于2017年10月至2024年7月在布赖代的法赫德国王专科医院进行。普查抽样包括所有诊断为肾细胞癌的患者。使用SPSS 26版(纽约州阿蒙克:IBM公司)分析人口统计学、临床和组织病理学特征数据。

结果

肾细胞癌在男性和老年患者中更为常见,常伴有糖尿病和高血压等合并症。在肾细胞癌的组织病理学类型中,透明细胞肾细胞癌(ccRCC)最常见,占患者的60.3%,其次是嫌色细胞肾细胞癌(chRCC)和乳头状肾细胞癌(pRCC),分别占患者的16.4%和11%。65.8%的肿瘤为福尔曼2级,表明其为中度侵袭性形式。偶然诊断的患者占45.2%,93.2%的患者在诊断时无转移证据。肾细胞癌的主要治疗方式是腹腔镜手术,52.1%的病例接受了该手术。

结论

ccRCC在各种形式的肾癌中患病率最高,大多数病例为偶然诊断。尽管发病率不断上升,但在卡西姆地区,早期诊断和改进筛查策略仍有待阐明,以应对肾细胞癌及其偶然发现率不断增加的负担。

相似文献

1
Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study.沙特阿拉伯卡西姆地区肾细胞癌的流行病学及治疗结果:一项回顾性研究
Cureus. 2024 Oct 31;16(10):e72748. doi: 10.7759/cureus.72748. eCollection 2024 Oct.
2
Exploring Renal Malignancies in Saudi Arabia: Insights from a Tertiary Care Center Study.
J Kidney Cancer VHL. 2023 Dec 18;10(4):13-19. doi: 10.15586/jkcvhl.v10i4.289. eCollection 2023.
3
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.嫌色性肾细胞癌的临床行为比透明细胞肾细胞癌的侵袭性小,这与Fuhrman分级或肿瘤大小无关。
Virchows Arch. 2014 Oct;465(4):439-44. doi: 10.1007/s00428-014-1648-9. Epub 2014 Sep 2.
4
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.肾细胞癌:MRI估计的扩散加权表观系数在改善其鉴别诊断、组织学亚型分类及分化程度判断方面的适用性
Int Urol Nephrol. 2017 Feb;49(2):215-224. doi: 10.1007/s11255-016-1460-3. Epub 2016 Nov 16.
5
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.肾细胞癌中新型预后标志物的鉴定与验证
Dan Med J. 2017 Oct;64(10).
6
An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.1 型与 2 型形态亚型的乳头状肾细胞癌的流行病学和临床病理研究——来自冰岛一项涵盖 50 年的全国性研究的结果。
BMC Urol. 2024 May 13;24(1):105. doi: 10.1186/s12894-024-01494-9.
7
Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.分析不同组织病理学类型的肾细胞癌的 CT、MRI 影像学特征。
J BUON. 2021 Sep-Oct;26(5):2053-2058.
8
Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma.临床晚期乳头状和嫌色细胞肾细胞癌的临床病理和生存分析。
Urol Oncol. 2019 Oct;37(10):727-734. doi: 10.1016/j.urolonc.2019.05.008. Epub 2019 Jun 5.
9
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.组织学亚型对肾细胞癌患者手术后复发的发生率、时间和模式的影响——来自 RECUR 联盟的结果。
Eur Urol Oncol. 2021 Jun;4(3):473-482. doi: 10.1016/j.euo.2020.09.005. Epub 2020 Oct 24.
10
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.嫌色细胞肾细胞癌(RCC):大型多中心系列中的肿瘤学结果和预后因素。
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

本文引用的文献

1
Obesity and renal cell carcinoma: Biological mechanisms and perspectives.肥胖与肾细胞癌:生物学机制与展望。
Semin Cancer Biol. 2023 Sep;94:21-33. doi: 10.1016/j.semcancer.2023.06.001. Epub 2023 Jun 5.
2
The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study.健康生活方式指数评分与荷兰队列研究中肾细胞癌风险的关联。
BMC Cancer. 2023 Feb 16;23(1):156. doi: 10.1186/s12885-023-10627-6.
3
Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma.
内脏和皮下脂肪与肾细胞癌的肿瘤分期和 Fuhrman 分级的关系。
Sci Rep. 2022 Oct 6;12(1):16718. doi: 10.1038/s41598-022-20877-2.
4
Trends of cancer incidence in Qassim Region, a descriptive analysis of data from the Saudi Cancer registry 2002-2016.卡西姆地区癌症发病率趋势:对沙特癌症登记处2002 - 2016年数据的描述性分析
Int J Health Sci (Qassim). 2022 Sep-Oct;16(5):21-31.
5
Epidemiology of Renal Cell Carcinoma: 2022 Update.肾细胞癌的流行病学:2022 年更新。
Eur Urol. 2022 Nov;82(5):529-542. doi: 10.1016/j.eururo.2022.08.019. Epub 2022 Sep 10.
6
Epidemiology and Prevention of Renal Cell Carcinoma.肾细胞癌的流行病学与预防
Cancers (Basel). 2022 Aug 22;14(16):4059. doi: 10.3390/cancers14164059.
7
New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future.肾癌的新型治疗干预措施:展望未来
Cancers (Basel). 2022 Jul 25;14(15):3616. doi: 10.3390/cancers14153616.
8
Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.肾细胞癌:流行病学、诊断和治疗概述。
G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3.
9
Characteristics of renal cell carcinoma in Saudi patients below the age of 50 years.沙特50岁以下患者肾细胞癌的特征。
Urol Ann. 2022 Jan-Mar;14(1):15-20. doi: 10.4103/ua.ua_14_21. Epub 2021 Dec 28.
10
The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies.饮食在肾细胞癌发病中的作用:观察性研究荟萃分析的伞状评价。
BMC Med. 2022 Feb 3;20(1):39. doi: 10.1186/s12916-021-02229-5.